Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic ModalitiesRoel Nusse(Howard Hughes Medical Institute), Hans Clevers(University Medical Center Utrecht)CellJune 1, 201710.1016/j.cell.2017.05.016Cited by 4,400Open AccessFull TextSaveCiteExport RISWatch citationsAbstractRelated PapersSingle Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal nicheToshiro Sato, Robert G.J. Vries, Hugo J.G. Snippert et al.|Nature|2009|7.1kActivation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APCPatrice J. Morin, Andrew B. Sparks, Vladimír Kořínek et al.|Science|1997|3.9kSingle-cell messenger RNA sequencing reveals rare intestinal cell typesDominic Grün, Anna Lyubimova, Lennart Kester et al.|Nature|2015|1.3kEpithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4Kevin L. Stark, Seppo Vainio, Galya Vassileva et al.|Nature|1994|1.1kStructural Basis of Wnt Recognition by FrizzledClaudia Y. Janda, Deepa Waghray, Aron M. Levin et al.|Science|2012|874